Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02792582 : A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
PhasePhase 2
AgesMin: N/A Max: 21 Years
Eligibility
Inclusion Criteria:

- Craniopharyngioma diagnosed by histology, cytology or neuroimaging or intra-operative
assessment

- Patients ages 0-21 years at the time of diagnosis

Exclusion Criteria:

- Prior history of fractionated radiation therapy

- Prior treatment with intracystic P-32 or intracystic bleomycin

- Pregnant females are excluded. Radiation has teratogenic or abortifacient effects
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02792582      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740